These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 10433350)

  • 1. Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus.
    Evans A; Krentz AJ
    Drug Saf; 1999 Jul; 21(1):7-22. PubMed ID: 10433350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Perry CM
    Drugs; 2004; 64(22):2577-95. PubMed ID: 15516157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments and emerging therapies for type 2 diabetes mellitus.
    Evans AJ; Krentz AJ
    Drugs R D; 1999 Aug; 2(2):75-94. PubMed ID: 10820647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral antidiabetic agents. A guide to selection.
    Scheen AJ; Lefèbvre PJ
    Drugs; 1998 Feb; 55(2):225-36. PubMed ID: 9506242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.
    Goudswaard AN; Furlong NJ; Rutten GE; Stolk RP; Valk GD
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003418. PubMed ID: 15495054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of type 2 diabetes mellitus in the elderly: special considerations.
    Rosenstock J
    Drugs Aging; 2001; 18(1):31-44. PubMed ID: 11232737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.
    Camacho P; Pitale S; Abraira C
    Drugs Aging; 2000 Dec; 17(6):463-76. PubMed ID: 11200307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Acta Clin Belg; 1993; 48(4):259-68. PubMed ID: 8212978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.
    Gough SC; Tibaldi J
    Clin Drug Investig; 2007; 27(5):299-324. PubMed ID: 17451279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising therapy for insulin-treated type 2 diabetes mellitus.
    Hermann LS
    Drugs Aging; 2000 Oct; 17(4):283-94. PubMed ID: 11087006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.